Clinical Trial Update: Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter [Phase 3]

View source ↗

Summary

Phase 3 trial update of once-daily rivaroxaban for treating thrombus in the left atrium/left atrial appendage in nonvalvular atrial fibrillation or atrial flutt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED